UK markets closed

Alternaturals, Inc. (ANAS)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00420.0000 (0.00%)
As of 01:37PM EDT. Market open.

Alternaturals, Inc.

50 West Liberty Street
Suite 880
Reno, NV 89501
United States

Sector(s)Financial Services
IndustryShell Companies
Full-time employees2

Key executives

NameTitlePayExercisedYear born
Mr. Joseph A. Cilento CMB, CPADirector and CEO, President & Director of United National Inc36kN/A1954
Mr. Ted BenyovitsChairman and ConsultantN/AN/AN/A
Mr. Steven BrownPresident, Treasurer & DirectorN/AN/AN/A
Mr. Edward HerbertCOO, Secretary & DirectorN/AN/AN/A
Mr. Mark FigulaChief Technology OfficerN/AN/AN/A
Amounts are as of 31 December 2000, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Alternaturals, Inc. manufactures and distributes supplements and all-natural remedies that are alternatives to prescription drugs. Its products include Focamine, an all-natural focus, attention, and concentration promoter for people suffering from ADHD; and Sombium, an alternative sleep aid. The company was formerly known as Zhong Nong Yuan Fang Holdings, Inc. and changed its name to Alternaturals, Inc. in March 2022. Alternaturals, Inc. was incorporated in 1995 and is based in Reno, Nevada.

Corporate governance

Alternaturals, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.